$5.10 0.01 (+0.20%)
2/10/2012 4:00 PM

SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)

CAPS Rating: 4 out of 5

A biopharmaceutical company, which is engaged in the development and commercialization of novel therapeutics to treat life-threatening diseases.

Featured Broker Partners


Advertisement